PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma

Clinical trial NCT03299309 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03299309
Sponsor: Daniel Landi
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Medulloblastoma Recurrent Brain Tumor, Childhood Malignant Glioma

Start date: 2018-06-29
Primary completion: 2023-04-27
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.